Gastricsin and cathepsin D in normal and hypertrophic human prostates.
The relative contents of gastricsinogen, the inactive zymogen precursor of gastric gastricsin (EC 3.4.23.3), and cathepsin D (EC 3.4.23.5) in normal and benign hyperplasia of the prostate gland have been determined. Gastricsinogen levels are significantly lower (0.116 +/- 0.02 U/gm. wet tissue) in the hyperplastic than in normal prostates (0.65 +/- 0.06 U/gm.). Conversely, cathepsin D levels are higher in the diseased (0.705 +/- 0.17 U/gm.) as opposed to normal prostatic tissue (0.39 +/- 0.12 U/gm.). The average gastricsin-cathepsin D differences between the 2 tissues (0.26 +/- 0.025 for normal prostates and -0.59 +/- 0.057 SEM for hyperplastic tissue) are also significantly different (p less than 0.001). It is suggested that the simple determination of these 2 acid proteinases in prostate homogenates could be used as alternative and complementary marker enzymes for the study of the physiopathologic status of the prostate gland.
D000135:Acid Phosphatase / Q000032:analysis; D002402:Cathepsin D; D002403:Cathepsins / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D010434:Pepsin A / Q000032:analysis*; D011467:Prostate / Q000201:enzymology*; D011470:Prostatic Hyperplasia / Q000201:enzymology*
D000135:Acid Phosphatase; D002403:Cathepsins; D010434:Pepsin A; C020557:gastricsin; D002402:Cathepsin D